- Home
- VLTO vs DXCM Comparison
VLTO vs DXCM Comparison
Compare VLTO & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VLTO | DXCM |
|---|---|---|
| Founded | 2023 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electrical Products | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.5B | 34.4B |
| IPO Year | 2023 | 2005 |
Fundamental Metrics
Financial Performance| Metric | VLTO | DXCM |
|---|---|---|
| Price | $118.14 | $80.98 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 17 | 29 |
| Target Price | ★ $124.63 | $98.15 |
| AVG Volume (30 Days) | 1.9M | ★ 4.8M |
| Earning Date | 10-29-2026 | 10-29-2026 |
| Dividend Yield | ★ 0.44% | N/A |
| EPS Growth | 12.57 | ★ 47.18 |
| EPS | ★ 3.03 | 1.87 |
| Revenue | ★ $5,503,000,000.00 | N/A |
| Revenue This Year | $7.96 | $12.14 |
| Revenue Next Year | $5.25 | $10.36 |
| P/E Ratio | ★ $38.64 | $42.60 |
| Revenue Growth | ★ 5.97 | N/A |
| 52 Week Low | $80.03 | $55.84 |
| 52 Week High | $119.03 | $92.59 |
Technical Indicators
Market Signals| Indicator | VLTO | DXCM |
|---|---|---|
| Relative Strength Index (RSI) | 85.31 | 45.87 |
| Support Level | $91.59 | $76.52 |
| Resistance Level | N/A | $91.05 |
| Average True Range (ATR) | 2.93 | 3.27 |
| MACD | 1.29 | 0.21 |
| Stochastic Oscillator | 97.31 | 32.56 |
Price Performance
Historical ComparisonAbout VLTO Veralto Corp
Veralto is a diversified industrial firm organized into two segments. The water quality segment offers water analytics and water treatment solutions, while the product quality and innovation segment offers coding, packaging, and color solutions for consumer packaged goods and pharmaceuticals. Headquartered in Waltham, Massachusetts, the company has around 17,000 employees. Veralto generated approximately $5.5 billion in revenue in 2025.
About DXCM DexCom Inc.
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery. DexCom's CGMs are available through medical equipment distributors as well as retail pharmacies.